Stay updated on Tagraxofusp in CD123+ AML Clinical Trial

Sign up to get notified when there's something new on the Tagraxofusp in CD123+ AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tagraxofusp in CD123+ AML Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer now identifies the site as running revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-01T16:02:24.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning from using “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    0.8%
    Check dated 2026-10-25T15:55:32.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The displayed site revision changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T22:20:43.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T22:35:23.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the record history, indicating an updated version of the study record. The older revision v3.6.6 was removed from the visible history.
    Difference
    0.1%
    Check dated 2026-09-20T20:38:58.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The study record history adds a new revision label v3.6.6 and removes the previous label v3.6.5. This reflects an update to the page's versioning history without altering the underlying content.
    Difference
    0.1%
    Check dated 2026-08-30T22:19:25.000Z thumbnail image

Stay in the know with updates to Tagraxofusp in CD123+ AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tagraxofusp in CD123+ AML Clinical Trial page.